GlassScriptPhysician profile
Catherine Olsen
NPI 1811062235
$28,345.33
in general payments reported to CMS, 2019-2025
32 companies · $9,636 in 2025
The $9,636 reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $66.80 · 2021: $255 · 2022: $261 · 2023: $8,709 · 2024: $9,146 · 2025: $9,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Food and Beverage: $2,061 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Travel and Lodging: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Food and Beverage | $2,061.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Travel and Lodging | $429.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,384.02 | 2023-2025 | Da Vinci Surgical System |
| Abbvie INC. | $366.42 | 2019-2022 | |
| Ethicon US, LLC | $146.94 | 2019-2025 | Stratafix, Ethicon, Harmonic |
| Daiichi Sankyo INC. | $137.68 | 2023-2024 | Injectafer |
| Astellas Pharma US INC | $137.22 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $118.94 | 2021-2024 | |
| Medtronic, INC. | $105.56 | 2025 | Valleylab Ft10 |
| Organon LLC | $94.77 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $94.01 | 2023-2025 | |
| Exeltis, USA INC. | $79.85 | 2021-2025 | Slynd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.56 | 2020-2024 | Xifaxan |
| Therapeuticsmd, INC. | $74.92 | 2019-2022 | |
| Abbott Laboratories | $48.77 | 2024-2025 | Freestyle Libre 3 |
| Minerva Surgical, INC | $47.26 | 2021-2022 | |
| Myovant Sciences INC. | $42.75 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $40.78 | 2020-2023 | Balcoltra |
| Novo Nordisk INC | $37.09 | 2023-2024 | Wegovy, Saxenda |
| Smith+Nephew, INC. | $35.08 | 2025 | Pico 7 |
| Millicent US INC | $33.66 | 2019-2025 | Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $30.67 | 2019 | |
| Shield Therapeutics INC | $24.91 | 2024 | |
| Dexcom, INC. | $23.31 | 2025 | Dexcom G6 Transmitter |
| Meditrina | $22.87 | 2023 | |
| Sumitomo Pharma America, INC. | $21.16 | 2024 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $18.29 | 2019 | |
| Hologic Sales and Service, LLC | $17.92 | 2020 | |
| Exact Sciences Corporation | $16.85 | 2025 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $16.01 | 2023 | Bd Onclarity |
| Currax Pharmaceuticals LLC | $13.75 | 2025 | Contrave |
| Takeda Pharmaceuticals U.S.A., INC. | $13.73 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.41 | 2019 | |
| Channel Medsystems, INC. | $11.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Olsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.